Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/303% below fair value
$26.96−1.05 (-3.75%)
Close on Nov 17, 2026Market cap $4.48BP/E –Yield –
Ionis Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ionis Pharmaceuticals's price to book ratio was 10.7× on Nov 11, 2026, against 21.6× a year earlier. Over the last 5 years it ranged from 6.1× to 27.1×, with a median of 13.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.7× | −10.0 |
| 2025 | Dec 31, 2025 | 20.6× | +12.3 |
| 2024 | Dec 31, 2024 | 8.3× | −14.7 |
| 2023 | Dec 29, 2023 | 23.0× | +14.0 |
| 2022 | Dec 30, 2022 | 9.0× | +0.9 |
| 2021 | Dec 31, 2021 | 8.1× | +2.4 |
| 2020 | Dec 31, 2020 | 5.7× | −0.6 |
| 2019 | Dec 31, 2019 | 6.4× | −4.1 |
| 2018 | Dec 31, 2018 | 10.5× | −9.9 |
| 2017 | Dec 29, 2017 | 20.4× | −21.1 |
| 2016 | Dec 30, 2016 | 41.5× | +11.2 |
| 2015 | Dec 31, 2015 | 30.3× | +9.2 |
| 2014 | Dec 31, 2014 | 21.1× | +9.6 |
| 2013 | Dec 31, 2013 | 11.5× | +5.3 |
| 2012 | Dec 31, 2012 | 6.2× | +2.4 |
| 2011 | Dec 30, 2011 | 3.8× | −0.1 |
| 2010 | Dec 31, 2010 | 4.0× | – |
See a number that looks wrong?